SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
DexCom DXCM recently announced that it will begin rolling out its fully reimagined Stelo app experience in the United States ...
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of ...
FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, ...
Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor called Stelo has been cleared for use by the FDA. The new CGM is designed for patients with Type 2 diabetes who do ...
Dexcom has received Food and Drug Administration clearance for the first over-the-counter glucose sensor for children. The ...
Dexcom is transforming its Stelo CGM into a whole-family wellness device, securing FDA clearance for pediatric use and debuting new AI tools.
Oura Ring uses Stelo by Dexcom to show glucose patterns, meal responses, and Time Above Range for users tracking blood sugar ...
Medical Device Network on MSN
FDA clears Dexcom’s Stelo as first OTC glucose monitor for children
The FDA’s indication expansion for Dexcom’s Stelo makes it the first over the counter CGM available for children, including ...
Stelo will be the first glucose biosensor in the US cleared for use without a prescription Indicated for use for people 18 years and older who are not using insulin therapy A small, wearable sensor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results